MEI Pharma (Formerly Marshall Edwards)
Innovative oncology therapies targeting unmet medical needs in cancer treatment. Learn more
Launch date
Employees
Market cap
$20.4m
Enterprise valuation
($24m) (Public information from Sep 2024)
Share price
$3.14 MEIP
San Diego California (HQ)
Authorizing premium user...